SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing extreme volatility and intense community frustration as the stock hits new lows, with investors debating whether the current sell-off is a structural collapse or a significant long-term buying opportunity. While some users point to concerns over content quality and management's failure to deploy buybacks, others are actively accumulating shares, viewing the stock as an oversold quality play ripe for a reversal.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors weigh its deep-pocketed infrastructure spending on AI data centers against its significant, long-term strategic stakes in high-growth companies like SpaceX. While the community is actively debating the company's capital allocation and the impact of recent talent turnover, many are focusing on the stock's potential as a core defensive play within the volatile hyperscaler sector.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing heightened volatility and selling pressure as investors weigh strong underlying fundamentals against broader software sector rotation and concerns over international contract developments. Community sentiment remains deeply polarized, with many retail participants actively debating whether to accumulate during the current price consolidation or exercise caution amid persistent short-selling activity.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing a surge in community engagement following the launch of their Americas Quantum Space Initiative, which has sparked speculation about potential partnerships and long-term space-based revenue growth. Investors are actively debating the stock's valuation versus peer quantum companies, with many looking toward an upcoming webinar on neutral-atom computing advancements as a potential catalyst for price movement.

Alphabet Inc - Ordinary Shares - Class C

Alphabet shares are seeing volatility driven by high-profile AI talent departures and market skepticism regarding the massive capital expenditures required to sustain the current AI buildout. Investors are actively debating the long-term sustainability of hyperscaler spending, while simultaneously weighing Alphabet's diversified growth engines like Google Cloud and the potential for lucrative future stake realizations.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is facing intense volatility as traders speculate on potential takeover activity and analyze the impact of a newly appointed CEO against high short interest. Community sentiment is deeply divided, with many investors holding for a possible buyout or long-term turnaround, while others express frustration over stagnant price action and aggressive short-selling.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon Athletica is facing heavy selling pressure and intense community debate as the stock hits multi-year lows, driven by concerns over declining margins, tariff impacts, and recent controversies in China. While some investors view the current valuation as a compelling long-term buying opportunity given the company's cash position and history of profitability, others are actively betting against the brand, citing failed leadership, weakening consumer demand, and the risk of further downward price action.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility as investors weigh the company's ambitious revenue targets and capacity expansion against heavy insider selling and sector-wide supply chain scrutiny. The community remains deeply divided, with bulls pointing to explosive demand in optical interconnects and hyperscaler growth, while bears emphasize valuation concerns and technical pressure.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors aggressively position for the highly anticipated release of 52-week Phase 3 VELA trial data, which is widely expected to validate sonelokimab's best-in-class potential in treating hidradenitis suppurativa. The community is actively debating the timing of this readout alongside other catalysts like the IZAR-1 trial for psoriatic arthritis, with sentiment heavily focused on the drug's superior nanobody structure as a prime target for a strategic acquisition by big pharma.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing significant momentum and investor attention following the release of positive Phase 3 topline results for its MDD treatment, triggering robust community discussions regarding potential FDA approval timelines and long-term valuation. While the stock continues to rally on the back of this data, market participants remain actively divided between optimism over its clinical progress and cautious concerns surrounding future capital raises, dilution risks, and technical profit-taking.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Integra (IART) Shows Fast-paced Momentum But Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

IART vs. SONVY: Which Stock Is the Better Value Option?

Bruker Gains 50.3% in a Year: What's Driving the Rally?

BRKR's rally is fueled by BSI NANO growth, AI-driven metrology demand and gains in preclinical imaging despite tariff pressures.

NVST Stock Rallies 37.1% in a Year: What's Behind the Drive?

Envista rises 37.1% in a year as new dental product launches, margin gains, acquisitions and a strong balance sheet fuel growth.

Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?

PEN gains CE Mark in Europe for THUNDERBOLT, expanding stroke treatment access and advancing its global stroke care strategy.

Should You Retain Tempus AI Stock In Your Portfolio Now?

TEM's diagnostics growth and expanding data deals support momentum, but sizable GAAP losses and execution challenges could keep shares volatile.

Integra LifeSciences Holdings Corporation (IART) Hits Fresh High: Is There Still Room to Run?

Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Should You Continue to Hold PAHC Stock in Your Portfolio?

Phibro Animal Health gains from Animal Health strength and Zoetis MFA integration, but macro and FX headwinds remain as the stock rises 27.6% over the past year.

Should You Continue to Hold EW Stock in Your Portfolio?

Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

Integra Lifesciences Holdings Corp

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

IARTIntegra Lifesciences Holdings Corp

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IART News